We are proud to be part the international research project SciFiMed: Screening of inFlammation to enable personalized Medicine. With this international and interdisciplinary team we work on furthering immunological research and aim to enable new treatment methods and new approaches for the field of drug development. Prof. Pauly, entrusted with Read more...
Uden, The Netherlands, June 2019 – Mr. Ronald de Niet is pleased to announce the acquisition of Biocult. Biocult is an internationally operating company with 20 years’ experience in upscaling of monoclonal antibodies. Since Biocult was established in 1992, they have processed over 200 different cell lines including hybridomas, transfectomas. Read more...
Hycult Biotech participates in new H2020 project aiming at improved diagnostics and intervention strategies for chronic autoimmune diseases.